Therefore, new clinical trials using novel H4R antagonists might a promising treatment for patients with AD such as the H4R antagonist JNJ-39758979, which led to an improvement of inflammatory skin lesions in AD patients (193, 201). Here, HRH4 is linked to Alzheimer disease.